The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression

Jun Huang, U. Ging Lo, Shiqi Wu, Bin Wang, Rey Chen Pong, Chih Ho Lai, Ho Lin, Dalin He, Jer Tsong Hsieh, Kaijie Wu

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


The prognosis of bladder cancer (BCa) depends on several key factors including anatomical site, tumor grade, and stage. In general, muscle-invasive bladder cancer (MIBC) is associated with higher incidence of distant metastasis compared with Non-muscle-invasive bladder cancer (NMIBC). Treatment outcome of the patients with metastatic BCa has been very poor with ~15% of overall survival rate. Thus, it is apparently important to understand the underlying biology for metastatic progression of BCa. Although epithelial–mesenchymal transition (EMT) has long been implicated in BCa metastasis and treatment resistance, the underlying mechanism is not fully understood. In this study, we have identified that the expression of interferon induced protein with tetratricopeptide repeats 5 (IFIT5) is positively correlated with pathological characteristics, and predicts a poor prognosis of BCa patients. Since the function of IFIT5 in BCa has not yet been characterized, we demonstrate that IFIT5 can induce EMT, promote cell migration and invasion, and increase the expression of ICAM1 in BCa via down-regulation of mature miR-99a. Moreover, ICAM1 is shown as a direct target of miR-99a. Overall, we conclude that IFIT5 is a new oncogene in BCa.

Original languageEnglish (US)
Article number437
JournalCell Death and Disease
Issue number6
StatePublished - Jun 1 2019

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research


Dive into the research topics of 'The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression'. Together they form a unique fingerprint.

Cite this